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Regenerative endodontic procedure is introduced as a biologically based treatment for
immature teeth with pulp necrosis. Successful clinical and radiographic outcomes
following regenerative procedures have been reported in landmark case reports.
Retrospective studies have shown that this conservative treatment allows for continued
root development and increases success and survival rate of the treated teeth compared
to other treatment options. Although the goal of treatment is regeneration of a
functional pulp tissue, histological analyses show a different outcome. Developing
predictable protocols would require the use of key elements for tissue engineering: stem
cells, bioactive scaffolds, and growth factors. In this study we will review the evidence
based steps and outcomes of regenerative endodontics.
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reatment of immature necrotic teeth is a challenge in
endodontics. Arrested root development following
pulp necrosis can lead to weak root structure with thin
dentinal walls, which makes the tooth susceptible to fracture
and reduces its survival rate [1]. Historically, multiple visit
apexification with calcium hydroxide was the treatment of
choice in necrotic immature teeth to induce formation of an
apical hard tissue barrier [2]. While this approach was
predictable and successful , long term use of calcium
hydroxide has several disadvantages that includes multiple
treatment appointments, probable recontamination of the
root canal system, and increased brittleness of root dentin
which might increase the risk of cervical root fractures [3, 4].
Apical barrier technique or root canal obturation using
bioactive cements was introduced as an alternative technique
[5-7]. Although these techniques have reasonable success
rates in terms of periapical disease healing [8-10], none of the
aforementioned treatment approaches result in continued
root development and strengthening of root structure, and
therefore, the long-term structural integrity of the teeth may
be compromised.
Recently, a new approach has been introduced which is
aimed at regeneration of the pulp-dentin complex and
inducing root development in immature teeth with necrotic
pulps [11, 12]. The treatment is based on the presence of
viable Stem Cells from Apical Papilla (SCAP) which are the
source of primary odontoblasts in normal root development
process [13]. Under ideal circumstances such as absence of
bacteria and necrotic tissues, presence of an appropriate
scaffold, and a tight coronal seal, these cells might be able to
repopulate the root canal space and reestablish the pulp-
dentin complex.
In a recent protocol published by American Association
of Endodontists (AAE), the procedure for regenerative
endodontic treatments in immature teeth with necrotic
pulps, has three separate steps during at least 2 appointments
[14]. The first step is root canal disinfection with sodium
hypochlorite. Although the AAE’s recommended
concentration for NaOCl is 1.5%, there are several successful
clinical reports of using higher concentrations of NaOCl in
regenerative endodontic treatments including 6% [15, 16],
5.25% [17-19] and 2.5% [20-22]. The next level of the
disinfection consists of root canal dressing with an antibiotic
[17, 23] or calcium hydroxide paste [20, 24]. The goals for
this step are to control the patient’s acute symptoms (if
present) and to reach the highest possible level of disinfection
to make the root canal space an appropriate environment for
regenerating the pulp-dentin complex. The most prevalent
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antibiotic used for this purpose is an equal mixture of
metronidazole, minocycline, and ciprofloxacin, called the
Triple Antibiotic Paste (TAP). Studies on TAP have shown
its efficacy in disinfection of the root canal space [25] and
deep layers of dentin [26]. Although the most efficient
antibiotic against endodontic bacteria in this mixture is
minocycline [27], there are clinical reports of successful
disinfection of the root canals by using double antibiotic
paste (metronidazole and ciprofloxacin) [12, 28] and
modified TAP (metronidazole, ciprofloxacin, and cefaclor)
[29]. A recent review on the cases treated from 2004 to 2012
showed that the aforementioned disinfection protocol is a
successful strategy which has been documented with
radiographic healing of the periapical disease in all reported
cases [30]. The second step is preformed during the second
appointment which involves removing the canal dressing, a
final flush with 17% ethylenediaminetetraacetic acid (EDTA)
and inducing a blood clot inside the root canal space by
irritating the periapical tissues by means of a sterile hand file.
Use of EDTA at this step causes release of sequestered
growth factors form dentinal walls which promotes the
proliferation and differentiation of SCAP [31]. Another
potential source of growth factors in this treatment protocol is
the release of growth factors following disintegration of
platelets in blood clot [11]. The blood clot also acts as a
protein-rich scaffold and also delivers SCAP into the root
canal space. One study showed that the level of markers for
human stem cells in the blood clot formed inside the root canal
space is up to 600 times higher than the same markers in
peripheral blood [32]. Recent reports have shown that platelet-
rich plasma (PRP) can also be used as a scaffold at this step [33,
34]. As the third step, the blood clot has to be sealed by a
biocompatible material followed by restoration of the access
cavity. The most recommended biomaterial for sealing the
pulp space is mineral trioxide aggregate (MTA) [35]. One
study documented successful use of calcium enriched mixture
(CEM) cement as a sealing material on blood clot [23].
Retrospective outcome studies show that this new
treatment protocol for immature teeth with pulp necrosis
causes increase in root length and root wall thickness [36,
37]. Use of TAP as an intra-canal medicament is associated
with significantly greater increase in root wall thickness
compared to calcium hydroxide [36]. A recent study by
Jeeruphan et al. [37] showed that teeth treated by
regenerative endodontic treatment have significantly higher
survival rates and radiographic healing rates (of periapical
lesions), compared to teeth treated by apexification with
calcium hydroxide. Although the success and survival rate of
cases treated with regenerative endodontic procedures were
higher than cases treated with MTA apical plug, the
differences were not significant [37]. Based on these outcome
studies, this new protocol might be a better option for
treatment of immature teeth with necrotic pulp regardless of
the type of tissues formed inside the canal after treatment.
However, randomized clinical trials, which offer the highest
level of evidence, are still awaited.
Although there are several reports of favorable
outcomes of this treatment in the literature, this new
approach can potentially cause unfavorable outcomes, which
need to be addressed:
a) Discoloration: Tooth discoloration following regenerative
endodontic treatment is a serious problem. As showed by Kim
et al. the main cause of tooth discoloration is minocycline in
TAP [38]. Other studies have shown that TAP has the highest
discoloration potential among any other endodontic material
[39]. Using double antibiotic paste [12] or modified TAP [29]
might be the solution to prevention of discoloration caused by
minocycline. In addition, presence of MTA might be another
source for discoloration [18, 30] which can be prevented by
using alternative tooth-colored bioactive materials like CEM
cement over the blood clot [23, 40] which has been shown to
be biocompatible with acceptable sealing ability [41-43].
b) Unfavorable or no root development: Root development
in immature teeth includes increase in root length, increase
in wall thickness, and closure of the apex (root maturation).
Lack of the aforementioned criteria in root development has
been reported previously which can be considered as a
potential unfavorable outcome [18, 30, 44]. A review on
dental history of cases treated with regenerative endodontic
treatments revealed a relation between long-term pulp
necrosis before treatment (>6 months) and poor outcomes in
terms of root development [30]. This might be due to the
presence of well-established bacterial biofilms on the dentinal
walls which would be hard to remove with minimal or no
instrumentation as recommended in the AAE’s protocol.
Also, damage to the SCAP or Hertwig’s epithelial root sheath
due to long-term periapical infection or dental trauma have
been suggested as other reasons [12, 30]. Interestingly, all of
the reported cases with unfavorable or no root development
have shown complete radiographic healing of the periapical
lesions [30]. For traditional endodontic treatment, lowering
the bacterial load and preventing bacterial access to
periapical tissues might be conductive to healing. However, a
higher level of disinfection is required for pulp regeneration
[45]. Further, it is worth mentioning that in younger teeth,
bacteria can penetrate into more dentinal tubules and
advance deeper compared to older teeth [46]. Disinfection of
the root canal spaces of immature teeth is therefore quite
challenging, and there is a need to develop more effective
antimicrobial regimens to create an environment conducive
to predictable regeneration of the pulp-dentin complex and
root development.
c) Empty root canal spaces (no tissue regeneration): The
probability of empty root canal space after regenerative
endodontic treatment in cases with poor or no root
development was first discovered by Lenzi and Trope [47].
They treated two immature maxillary central incisors with
pulp necrosis and periapical lesions. Teeth were in different
stages of development. The one with shorter root and wider
apex had larger periapical lesion and showed no root
development 21 months after treatment. They hypothesized
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that the physically weak blood clot might have disintegrated
after treatment, leaving the root canal space empty.
However, they documented complete healing of the
periapical lesion on periapical radiographs and 3D images.
Nosrat et al. documented empty root canal spaces clinically
in two maxillary central incisors 6 years after regenerative
treatment [30]. Both teeth showed complete healing of the
periapical lesions and radiographic signs of apical closure
(root maturation) without increase in root length or wall
thickness. Since the exact criteria for success of the
treatment has not been determined yet, these findings
might not be considered as “clinical failures” but show that
the outcome of the current protocol for pulp regeneration
might be unpredictable.
Histological outcomes of animal studies
Animal studies on the protocol for pulp regeneration have
documented the formation of new hard tissues on root
dentinal walls and apical closure in radiography and histology.
They also showed new tissues growing into the root canal
space [48-50]. All of these studies have been conducted on dog
models. Thibodeau et al. evaluated the effect of blood clot and
a soluble collagen scaffold on the outcome of the treatment
[48]. They showed that the amount of vital tissues inside the
root canals and the amount of hard tissue deposited on the
dentinal walls were not different in the presence or absence of
blood clot inside the root canal space. In addition, presence of
a soluble collagen scaffold did not improve the results. Detailed
histological evaluation of the same specimens by Wang et al.
revealed that there were three types of tissues formed inside
the root canals following the treatment: cementum-like tissue
which was responsible for increase in root length and
thickness, bone-like tissue, and periodontal ligament (PDL) like
tissue inside the canal space [49]. da Silva et al. showed that the
vital tissue formed inside the root canal space after treatment is
generally an ingrowth of periodontal connective tissue to the
root canal space [50]. An interesting finding in this study was
presence of inflammation in almost all of the specimens in
experimental groups. They also showed that using EndoVac
with NaOCl for root canal irrigation would be a better option
than irrigation with NaOCl plus TAP dressing. Yamauchi et al.
attempted to perform pulp regeneration in a dog model by
adding an insoluble collagen scaffold to the blood clot and
using 17% EDTA [51]. EDTA was used as a demineralizing
agent to release growth factors embedded in dentinal walls and
expose dentine matrix and therefore, promote differentiation
of mesenchymal cells. Immuno-histochemical analysis of the
tissues formed after the treatment showed that the hard tissue
formed on the dentinal walls was a cementum-like tissue with
different organization and maturation of collagen fibers.
All of these animal studies showed that the recent
protocol of pulp regeneration is not predictable in terms of
type of tissues formed inside the root canal and on the
dentinal walls. However, none of these animal studies
investigated the presence of stem cells in the apical papilla
after inducing the periapical infection, or in the blood clot.
Histological reports of human teeth
The first histological report of outcome of pulp regeneration in
human teeth was done by Torabinejad and Faras [52]. In this
study root canal treatment was performed in a maxillary
premolar which had received regenerative endodontic
treatment by using PRP as scaffold 14 months before. Because
of the method of tissue sampling they were not able to provide
information about pulp-dentin complex and the hard tissue
deposited on the root canal walls. They showed presence of a
pulp-like connective tissue inside the canal. Shimizu et al.
performed histological evaluations on a maxillary central
incisor three and a half weeks after treatment [53]. The tooth
was extracted because of an oblique enamel-dentin fracture
due to a traumatic impact. They showed that the tissue inside
the root canal was a loose connective tissue similar to an
immature pulp containing spindle-shaped fibroblasts and
mesenchymal cells. Another report on the histological
outcome of the treatment in human teeth was done by Martin
et al. [54]. They performed regenerative endodontic treatment
in a mandibular molar by using PRP in distal canal and blood
clot in mesial canals. The tooth was extracted 25 months after
the treatment because of an oblique fracture of the lingual
cusps. The mineralized tissue formed on the root canal walls
was cementoid/osteoid tissue and the root canal spaces were
filled with vital connective tissue and blood vessels. Regardless
of the scaffold type, they showed that there was no pulp tissue
inside the roots.
All in all, the aforementioned data shows that although
the recent protocol for pulp regeneration has higher success
rate and survival rate compared to other methods of
treatment for immature teeth with pulp necrosis, the
biological outcome of the treatment is still not predictable
and it may not be true pulp regeneration. Part of the problem
might be related to the disinfection strategies. A study by
Trevino et al. showed that full strength NaOCl is toxic to
SCAP and prevents repopulation of SCAP on dentinal walls
[55]. Investigation of the ability of dental pulp stem cells
(DPSCs) to adhere to dentin after being exposed to different
irrigants revealed that irrigation with NaOCl was related to a
lower degree of cell adherence [56]. In addition, denaturation
of dentinal proteins by NaOCl interferes with differentiation
of stem cells in contact with dentin [57]. Routine antibiotic
dressings with creamy consistency might be another threat to
pulp regeneration. A recent study by Ruparel et al. showed
that TAP with creamy consistency (1000 mg/mL) would be
extremely toxic to SCAP [58]. The study revealed that a
concentration of 0.01 to 0.1 mg/mL would be conducive to
SCAP survival. A low concentration of antibiotic is a watery
solution which would not be stable inside the root canal
space and therefore, a biocompatible carrier has to be used to
hold the dressing for a few weeks. Besides, the antibacterial
efficacy of antibiotics in this low concentration is another
concern which deserves further studies.
It has been proposed that the way forward is to develop
therapies based on sound tissue engineering principles using a
triad of stem cells, growth factors and bioactive scaffolds [11].
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There are advantages in such attempts to direct or orchestrate
the regenerative process including futuristic possibilities such
as being able to custom design a pulp with appropriate
immune response, vitality and sensibility. Controlled
regeneration would also avoid unfavorable outcomes, and
applications for treating mature teeth could be developed. The
regenerated pulp tissue could potentially be directed to produce
a dentin overlay precisely where needed to restore damaged
tooth structure, or to increase root length and root thickness.
Potential role of stem cells
During wound healing after pulp exposure, the
undifferentiated mesenchymal cells migrate to the site of
exposure from the deeper regions of the pulp, and replace
degenerated odontoblasts [59]. An extension of this concept is
that in regenerative endodontic treatment of cases with pulp
necrosis, stem cells are required to achieve the goal of
replacing the diseased pulp tissue with a regenerated healthy
pulp that would continue normal dentinogenesis. The ideal
healthy pulp would be capable of a robust immune response,
and exhibit vitality through blood supply and sensibility
through nerve supply. Vascular and neural regeneration require
stem cells to differentiate into respective progenitor cells.
Stem cells have several unique characteristics. They exist
as undifferentiated cells and maintain this phenotype until
they are exposed to the appropriate signals. They have
extensive self-replication capacity, and can maintain
themselves throughout the life of an organism. Stem cell
populations are found in most adult tissues. Adult stem cells
have more restricted differentiation potential than embryonic
stem cells, but they avoid the ethical constraints of the latter
and are thus well suited for research and clinical therapies [60].
Current clinical protocols in regenerative endodontics
are probably utilizing indigent stem cells to form progenitor
cells, but they make no attempt to orchestrate the
regenerative process, and the histologic character of the
tissues formed is quite variable. These indigent stem cells
come from the following sources:
a) Stem cells of the apical papilla (SCAP)
These are a population of mesenchymal stem cells (MSCs)
residing in the apical papilla of incompletely developed teeth.
SCAP appear to be the source of primary odontoblasts that
are responsible for the formation of root dentin, whereas
dental pulp stem cells (DPSCs) are likely the source of
replacement odontoblasts [13]. When transplanted
subcutaneously into immuno-compromised mice, they have
been shown to differentiate into odontoblasts and form
dentin [61]. Because of its apical location, the apical papilla
has collateral circulation and this enables it to survive during
the process of pulp necrosis. The evoked bleeding step in
current clinical protocols for pulp regeneration triggers the
significant accumulation of stem cells into the canal space
[32]. These cells are likely to be SCAP cells and might
contribute to the regeneration of pulpal tissues.
b) Dental pulp stem cells (DPSCs)
Human DPSCs have self-renewal capability and multi-
lineage differentiation potential in vitro [62, 63], including
dentinogenic potential [64, 65]. Many cases being treated by
regenerative endodontics have residual inflamed pulp tissue,
and it has been shown that this tissue contains DPSCs, which
retain tissue regeneration potential [66].
c) Periodontal ligament stem cells (PDLSCs)
PDL contains stem cell populations that can differentiate into
cementoblasts or osteoblasts [67, 68]. PDLSCs exhibit
osteogenic, adipogenic and chondrogenic capacity under
defined culture conditions, but they don’t seem to be
dentinogenic [69-71]. The evoked bleeding step in current
clinical protocols may also lead to PDLSCs accumulation in
the root canal, and they may be responsible for the bone-like
tissues formed in the canal in some animal studies [72].
Several case reports have shown successful outcomes
with regenerative endodontic treatment, in terms of lesion
resolution and increase in root length and/or thickness [18,
23, 33]. In such cases when complete success is not achieved,
conventional non-surgical root canal treatment or MTA
apexification is still feasible and often made technically easier
due to some degree of apical closure from the regenerative
treatment. It has been shown that the public health impact of
regenerative endodontics is limited unless its applications are
expanded to treat teeth in adult patients with mature apices
[73]. These patients have no SCAP cells, and the supply of
indigent stem cells in the periapical areas may vary with the
age of the patient and size of the periapical lesion.
There are two major approaches to deliver stem cells
into the root canal for pulp regeneration:
i. Cell transplantation
This involves direct delivery of autologous or allogeneic stem
cells into the root canals. Studies in animals have shown
promising results with this approach for regenerative
endodontics [74-76]. There is still a need for good in situ
models for human regenerative procedures, as they would be
used on patients. The major roadblocks for clinical translation
are immune rejection potential (for allogeneic cells), regulatory
approval for using in patients, and high cost. Mesenchymal
stem cells have reduced immunogenicity because they are able
to avoid the immune response and they also make factors that
suppress the immune response [77]. These stem cells home to
injured tissues and modulate the inflammatory response
through synergistic down-regulation of pro-inflammatory
cytokines and up-regulation of pro-survival and anti-
inflammatory factors [78]. Immunocompatible off-the-shelf
allogeneic stem cells could potentially be used to formulate a
viable commercial product to use for total dentin-pulp
regeneration in endodontic practice.
ii. Cell homing
This involves the use of chemotactic factors like Stromal Cell
Derived Factor (SDF)-1 that can induce migration of stem cells
from the periapical area into the root canal. Immune rejection
is therefore not an issue. This has been investigated in animal
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models as an adjunct to stem cell transplantation, but not as a
stand-alone technique [74, 79]. The regulatory approval
process to use this technique in human patients would be
much easier, and the cost much lower. However, the results
may depend on the distance that cells need to migrate, so the
longer the root length, the less favorable the prognosis would
be. Also adult patients that have fewer or no indigent stem cells
may not be candidates for such treatment, and it has been
shown that these patients comprise the majority of the patient
population in endodontic practices [73]. Large periapical
lesions may require very long treatment times, because a high
level of disinfection is a prerequisite for successful regeneration
[45], and a long time would be needed to wait for lesion
resolution so that a source of stem cells to become available for
homing into the root canal space.
The first manufactured medicament based on allogeneic
stem cell transplantation was recently granted regulatory
approval to treat children suffering from graft-versus-host
disease (GVHD). Stem cell banking of Stem Cells from
Exfoliated Deciduous teeth (SHED) and DPSCs from
extracted third molars has already been commercialized in
anticipation of clinical therapeutic applications. Inflamed
pulp tissues are currently discarded as medical waste, but
they have been shown to contain stem cells with regenerative
potential and may be considered as an alternative and more
attainable source of DPSCs [66]. The timeline for translation
of tissue engineering into clinical endodontic practice
remains to be seen, but there already appears to be an
explosion of basic science research in this field.
Potential role of bioactive scaffolds
An ideal scaffold should have the following characteristics for
successful tissue regeneration: capability for seeding of
stem/progenitor cells or supplementation with growth
factors, controlled biodegradability to be eventually replaced
with natural tissue, adequate biomechanical properties,
bioactivity to facilitate attachment to soft and hard tissues,
biocompatibility with the host tissue, osteoinductivity and
angiogenic potential.
The most frequently used scaffold in regenerative
endodontics is a blood clot [35]. The fate of blood clot in
apical area of root canal after conventional root canal
treatment was explored by Nygaard Østby in the early
1960s [80]. The blood clot produced by platelet aggregation
was gradually transformed into fibrous connective tissue
over time even in cases where the initial diagnosis had been
pulp necrosis with apical periodontitis. In the current AAE
protocol for regenerative endodontics [14], blood clot
induced by lacerating periapical tissue with overextended
file is suggested as a scaffold and also as the way to bring
SCAP into the root canal [81]. Following the seminal case
report by Banchs and Trope, blood clot has been used in
revascularization of immature permanent teeth [17],
regardless of the differences in disinfection protocol such as
concentration of sodium hypochlorite and type of
antibiotics [17, 23, 29]. The evoked bleeding from apical
papilla into root canal showed significant accumulation of
transcripts for the stem cell markers CD73 and CD105,
compared with levels found in the systemic blood, which
suggests that these cells will contribute to the regeneration
of pulp tissue after disinfection of the root canal space [32].
It is recommended to use local anesthetics without
vasoconstrictors in order to induce sufficient amount of
bleeding into the root canal [18]. However, lack of bleeding
or insufficient bleeding even after using plain local
anesthetics has been reported [23, 24] and was associated
with poor root development in some cases [23]. The
absence of a blood clot has also been implicated in
unsuccessful outcomes of regenerative endodontics in an
animal study [48]. The use of PRP was suggested when it is
difficult to produce periapical bleeding by overextending a
file [33]. In an animal study comparing blood clot and PRP
for pulp regeneration, there was no difference between the
groups with respect to the presence of vital tissue and new
hard tissue formation inside the root canal [82]. In
addition, preparation of PRP involves additional steps
including drawing a blood sample from the patient and
centrifuging the blood with an anticoagulant. Behavior
management of young children who constitute the majority
of patients for regenerative endodontic procedures, can
therefore be an obstacle for clinical utilization of PRP [73].
In 1976, collagen-calcium phosphate gel was investigated
to close the apex of pulpless open apex teeth as an alternative
to calcium hydroxide apexification [83]. The result showed
that teeth filled with collagen-calcium phosphate gel appeared
to have connective tissue in growth and various forms of hard
tissue lining the root canal walls. The interesting point of this
study was that they did not add any stem/progenitor cells
(neither transplantation nor cell homing approach) or growth
factors to their scaffold, which are components of the tissue
engineering triad. Collagen has been used as a scaffold in
several in vivo experiments based on the tissue engineering
triad [84, 85]. The triad of DPSCs, collagen scaffold, and
Dentin Matrix Protein (DMP)-1 were placed in simulated
perforation sites in dentin slices [84]. After 6 weeks of
subcutaneous implantation on the dorsal surfaces of immuno-
deficient mice, organized matrix formation similar to that of
pulpal tissue was seen which might lead to hard tissue
formation. In the group using only collagen scaffold,
degrading collagen was observed without the presence of any
calcified tissues [84]. Collagen gel solution was successfully
used in a cell-homing approach to regeneration along with
multiple combined growth factors such as beta-Fibroblast
Growth Factor (bFGF), Vascular Endothelial Growth Factor
(VEGF), or Platelet-Derived Growth Factor (PDGF) with a
basal set of Nerve Growth Factor (NGF) and Bone
Morphogenetic Protein-7 (BMP7) [85].
Potential role of growth factors
The proliferation, differentiation, survival and motility of
DPSCs are regulated by a network composed of various
signaling molecules, receptors and transcription control
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systems in the pulp tissue. Multiple growth factors, including
BMPs, VEGF and Transforming Growth Factor beta
have been implicated in mediating these biological processes
and they can play potentially important roles in pulp
regeneration. It is necessary to integrate different signaling
pathways into a regulatory network to precisely orchestrate
gene expression. Therefore, an understanding of each growth
factor and its relationship with dental pulp stem cells is an
indispensable step in developing a predictable pulp
regeneration protocol.
Bone morphogenetic proteins (BMPs)
BMP was discovered by Urist in 1965 who showed that
demineralized lyophilized segments of rabbit bone induce
new bone in intramuscular sites [86]. Subsequently, BMPs
were isolated from adult bone matrix in mammals by
extracting demineralized bone matrix.
The human genome encodes 20 BMPs and this BMP
family can be divided into four distinct subfamilies: first,
BMP2 and 4; second, BMP3 and BMP3B; third, BMPs 5, 6, 7
and 8; and fourth, Growth Differentiation Factors (GDFs) 5, 6
and 7, also known as cartilage-derived morphogenetic proteins
1, 2 and 3 [87].
and their ability to induce formation of bone and cartilage
is well known [88]. In response to treatment with
recombinant human BMP2, pulp-derived mesenchymal
cells differentiate into dentin-forming pre-odontoblasts
[89]. When combined with total EDTA-soluble fraction of
stimulates odontoblast differentiation in organ cultures of
dental papilla cells [90].
When used as a pulp capping material over amputated
canine pulp in an in vivo model, human recombinant BMP2 or
BMP4 induces dentin formation [91]. In this study, human
recombinant BMP2 or BMP4 were added to dentin matrix
power, chondroitin 6-sulfate sodium salt, or type 1 rat tail
collagen, as carriers. After two months, the amputated pulp
was filled with tubular dentin in the lower part. However,
when BMP was delivered using reconstituted type I collagen
matrix, no distinct tubular dentine was formed, unlike an
earlier experiment in which BMP2 or BMP4 was implanted
with enriched, inactivated dentine matrix [92]. These findings
suggest that both BMP2 and BMP4 induce osteodentine
formation if combined with collagen matrix. However, some
other matrix components sequestered in inactivated dentine
matrix might be essential for further differentiation into
odontoblasts. Autologous transplantation of BMP11-
transfected cells cultured as a pellet stimulated reparative
dentin formation on amputated pulp in a dog model [93].
Vascular endothelial growth factor (VEGF)
The tissue engineering triad of scaffold, stem cells and
morphogens might be essential for successful pulp regeneration.
However, without proper angiogenesis/vasculogenesis to supply
enough nutrients and oxygen to the transplanted or migrated
stem cells into the root canal, pulp regeneration would not be
successful. VEGF is an excellent regulator of angiogenesis and is
known to increase vascular permeability.
VEGF is a potent endothelial cell mitogen and
angiogenic factor that has been shown to play a central role
in vascular responses that accompany a number of
physiological and pathological processes [94]. VEGF is
produced by a variety of cell types, including keratinocytes,
macrophages, mast cells, smooth muscle cells and several
types of tumors [94].
VEGF induces chemotaxis, proliferation and
differentiation of human dental pulp cells [95, 96]. In addition,
VEGF is also involved in the proliferation of endothelial cells,
enhances their survival in the toxic oxygen-deficient
environment, and stimulates neovascularization in the area of
injury [97]. In an in vivo study using the immunodeficient
mice model, tooth slices treated with 0 or 50 ng/mL
rhVEGF165 for one hour, demonstrated increased pulp
microvessel density, which is potentially beneficial for pulp
regeneration [98].
Dentin contains many growth factors including VEGF
and cytokines that are embedded in the matrix during
dentinogenesis through their interactions with non-
collagenous proteins and other extracellular matrix
components [99]. Among these growth factors, angiogenic
growth factors (VEGF) released from the matrix as a result of
matrix breakdown during tissue injury or during pulp
regeneration procedures by EDTA, could make an important
contribution to the overall reparative/regenerative response
of the dentine-pulp complex [100]. According to Zhang’s
study, dentin matrix components showed a dose-dependent
response in the expression of the proangiogenic growth
factor VEGF and its receptor VEGFR2 [101]. These
proangiogenic effects of relatively low concentrations of
dentin matrix components could be associated with
revascularization during pulp repair and regeneration.
was shown to stimulate type I collagen synthesis, alkaline
phosphatase activity, and in culture proliferation of
mammalian pulp cells [102, 103]. Results of a study by Melin
et al. could be directly involved in
the regulation of cell proliferation, migration, and extracellular
matrix production in human dental pulp [104]. Together with
STRO-1+ DPSCs in vitro with expression of dentin sialoprotein
(DSP) and dentin matrix protein (DMP)-1 mRNA [105].
papilla-derived cells as well as for other cell types [106]. At
the stage of cell recruitment, this chemotactic property of
tissue injury in the tooth.
The aforementioned growth factors could be
incorporated in tissue engineering scaffolds and delivered
into the root canal to promote pulp regeneration. However, it
is also been demonstrated that dentine matrix itself contains
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BMPs, FGF2, and Epidermal Growth Factor (EGF) which
stimulate and modulate many of the cellular events taking
place during pulp regeneration [100]. During the pulp
revascularization procedure with EDTA application and
induction of blot clot, growth factors would be released from
the dentin matrix and platelets. However, different
concentrations of the same molecules can show a spectrum
of effects ranging from inflammation or stimulation of
regeneration to cell apoptosis [107].
In a recent interesting study, a cell-homing approach
using growth factors was proposed to regenerate the pulp-
dentin complex rather than transplantation of
stem/progenitor cells in entire human teeth [85]. This study
showed cellularized and vascularized tissues and new dentin
formation over the surface of dentinal wall in endodontically
treated human teeth implanted in mouse dorsum. They
produced dental pulp-like tissue in the entire root canal by
using combined delivery of bFGF, VEGF, or PDGF, NGF and
BMP7. The cell homing strategy avoids the in vitro culture of
autologous cells and therefore it could be a simple, practical
and economical approach for pulp regeneration [108].
Conclusion
The current protocol for pulp regeneration shows promising
results in terms of healing of periapical lesions and survival
rate of treated teeth compared to traditional methods.
However, there are several problems with the protocol and
the outcomes are unpredictable. Therefore, every step in the
treatment protocol should be revised to attain a more
biocompatible strategy. More importantly, the effect of
adding tissue-engineering triad components (stem cells,
bioactive scaffolds and growth factors) to the current
protocol needs to be studied in more relevant in situ animal
models with immature teeth and concurrent pulp necrosis.
Conflict of Interest: ‘None declared’.
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